Showing 9611-9620 of 20873 results for "".
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
https://reachmd.com/programs/Audioabstracts/rebalancing-amyloid-attr-cm/49065/While transthyretin amyloid cardiomyopathy (ATTR-CM) is often viewed solely as a disorder of protein misfolding, a new review published in the European Heart Journal presents it as a dynamic imbalance between amyloid production and clearance. Hear from Dr. Hallie Blevins as she reviews pivotal dataAdvancing Pediatric MS Care: Insights from AAN 2026
https://reachmd.com/programs/neurofrontiers/pediatric-ms-aan-2026/54250/At the 2026 American Academy of Neurology (AAN) Annual Meeting, experts are sharing the latest developments in pediatric multiple sclerosis (MS). Dr. Elizabeth Wilson is here to share insights on how new adult MS research, neuro-ophthalmology collaboration, and emerging clinical data are shaIL-31’s Role in Prurigo Nodularis
https://reachmd.com/videos/dermatology-hub-neuroimmune-network/il-31s-role-in-prurigo-nodularis/48804/Raj Chovatiya, MD, PhD, MSCI, FAAD, explains the role of the IL-31 pathway in neuroinflammatory disease such as prurigo nodularis.Evidence Base for Treatment Strategies for Endometrial Cancer After Disease Progression and Interdisciplinary Collaboration
https://reachmd.com/programs/cme/Evidence-Base-for-Treatment-Strategies-for-Endometrial-Cancer-After-Disease-Progression-and-Interdisciplinary-Collaboration/39295/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Managing Immune-Related Adverse Events in Cervical and Endometrial Cancer
https://reachmd.com/programs/cme/Managing-Immune-Related-Adverse-Events-in-Cervical-and-Endometrial-Cancer/39296/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
https://reachmd.com/programs/eye-on-ocular-health/evaluating-eyelid-wipes-for-dry-eye-disease-clinical-trial-insights/37276/A recent study presented at the 2025 American Academy of Ophthalmology Annual Meeting evaluated a novel treatment option for dry eye disease: a TRPM8 agonist delivered via an eyelid wipe. Hear Dr. Houman D. Hemmati walk through the study's design, its findings on safety and efficacy, and the next stPractical Strategies for Improving Patient Adherence with Topical Regimens
https://reachmd.com/videos/dermatology-hub-neuroimmune-network/practical-strategies-for-improving-patient-adherence-with-topical-regimens/39707/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, describes tactics involving topical therapeutics to improve patient adherence with atopic dermatitis.Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
https://reachmd.com/programs/neurofrontiers/genetic-pathways-in-ms-the-clinical-impact-of-a-chromosome-2-variant/32820/In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of CalifornNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
https://reachmd.com/programs/clinicians-roundtable/navigating-treatment-goals-in-igan-the-impact-of-et-1-and-ang-ii/37214/Given that the endothelin-1 (ET-1) and angiotensin II (Ang II) pathways contribute to the pathogenesis of IgA nephropathy (IgAN), it’s important to set treatment goals that prevent disease progression. Joining Dr. Charles Turck to discuss the role and impacts of ET-1 and Ang II and how we can achievIncreased APS Risk for Psoriasis Patients, Plus More
https://reachmd.com/videos/dermwire-tv/increased-aps-risk-for-psoriasis-patients-plus-more/39299/This episode highlights research showing increased risk for anti-phospholipid syndrome (APS) in patients with psoriatic disease, as well as research showing increased risks for tuberculosis in patients treated with immunosuppressants. The episode also features a clip from an in-depth discussion arou